Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX8FYI
|
||||
| Drug Name |
(S)-2-((S)-1-(4-benzoylphenyl)-2,2,2-trifluoroethylamino)-N-(cyanomethyl)-4-methylpentanamide
|
||||
| Synonyms |
CHEMBL426493
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H24F3N3O2
|
||||
| Canonical SMILES |
CC(C)C[C@H](N[C@@H](c1ccc(cc1)C(=O)c2ccccc2)C(F)(F)F)C(=O)NCC#N
|
||||
| InChI |
InChI=1S/C23H24F3N3O2/c1-15(2)14-19(22(31)28-13-12-27)29-21(23(24,25)26)18-10-8-17(9-11-18)20(30)16-6-4-3-5-7-16/h3-11,15,19,21,29H,13-14H2,1-2H3,(H,28,31)/t19-,21-/m0/s1
|
||||
| InChIKey |
YNFROJBIFZUSFU-FPOVZHCZSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.